| Analysis | Metabolite Name | Measured Value | Units | level of dysplasia | malignant transformation |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID #2 (M-H)- | 3994 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID #2 (M-H)- | 4055 | Peak area | N/A | No |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID #2 (M-H)- | Peak area | HGD | No | |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID #2 (M-H)- | Peak area | HGD & PDA | yes | |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID #2 (M-H)- | Peak area | HGD & PDA | Yes | |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID #2 (M-H)- | Peak area | LGD | No | |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID #2 (M-H)- | Peak area | N/A | No | |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID (M-H)- | 9926 | Peak area | HGD & PDA | yes |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID (M-H)- | 11255 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID (M-H)- | 11541 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID (M-H)- | 15227 | Peak area | HGD | No |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID (M-H)- | 17151 | Peak area | HGD & PDA | Yes |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID (M-H)- | 17739 | Peak area | N/A | No |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID (M-H)- | 21955 | Peak area | N/A | No |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID (M-H)- | 25359 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID (M-H)- | 28864 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID (M-H)- | 71666 | Peak area | N/A | No |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID (M-H)- | 163151 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | BENZOIC ACID (M-H)- | Peak area | LGD | No |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|